have revealed that TNFR2+ Tregs (Figure 2) are presented at high levels within the ascites of ovarian cancer, which are more suppressive compared to peripheral blood TNFR2+ Tregs.210. This evidence concerns the gene TNFRSF1B and ovarian carcinoma.